Jeyakumar Meyyappan
@jeyakumarmeyyappan.bsky.social
Nephrologist , transplant physician
December 3, 2025 at 2:27 AM
November 19, 2025 at 2:07 AM
Reposted by Jeyakumar Meyyappan
Ongoing late posts from @theisn.org #ISNWCN
from the high impact trial session - this was a great study design
The India ALLIANCE GRACE IgAN trial
Lead by Succeena Alexander from CMC Vellore
#NephSky
1/
from the high impact trial session - this was a great study design
The India ALLIANCE GRACE IgAN trial
Lead by Succeena Alexander from CMC Vellore
#NephSky
1/
February 16, 2025 at 2:51 PM
Ongoing late posts from @theisn.org #ISNWCN
from the high impact trial session - this was a great study design
The India ALLIANCE GRACE IgAN trial
Lead by Succeena Alexander from CMC Vellore
#NephSky
1/
from the high impact trial session - this was a great study design
The India ALLIANCE GRACE IgAN trial
Lead by Succeena Alexander from CMC Vellore
#NephSky
1/
Reposted by Jeyakumar Meyyappan
First things first — where the story starts!
Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC
Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC
October 29, 2025 at 1:07 AM
First things first — where the story starts!
Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC
Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC
October 29, 2025 at 1:07 AM
Reposted by Jeyakumar Meyyappan
The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky
✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social
www.nephjc.com/news/igan-kd...
✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social
www.nephjc.com/news/igan-kd...
2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJC
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
www.nephjc.com
October 28, 2025 at 2:06 AM
The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky
✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social
www.nephjc.com/news/igan-kd...
✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social
www.nephjc.com/news/igan-kd...
#nephjc
Jeyakumar from India
I believe half of my patients here don’t even take half the of prescribed protein 0.8g/kg . Interested in learning from this systematic review
Jeyakumar from India
I believe half of my patients here don’t even take half the of prescribed protein 0.8g/kg . Interested in learning from this systematic review
October 15, 2025 at 1:06 AM
#nephjc
Jeyakumar from India
I believe half of my patients here don’t even take half the of prescribed protein 0.8g/kg . Interested in learning from this systematic review
Jeyakumar from India
I believe half of my patients here don’t even take half the of prescribed protein 0.8g/kg . Interested in learning from this systematic review
🗓️Join us 10/14/25 as we discuss:
Are you team PRO protein 💪 or team RESTRICT protein 🥗
The strategies seem to shift somewhat as CKD progresses to ESRD. What's the evidence say 🤔?
🕰️9pm EST only on Bluesky. #NephSky #MedSky
www.nephjc.com/news/proteins-eskd
Are you team PRO protein 💪 or team RESTRICT protein 🥗
The strategies seem to shift somewhat as CKD progresses to ESRD. What's the evidence say 🤔?
🕰️9pm EST only on Bluesky. #NephSky #MedSky
www.nephjc.com/news/proteins-eskd
The Protein Pendulum in CKD: supplement or restrict? — NephJC
This week, we will discuss an old dilemma in nephrology. To restrict or supplement the proteins? Premise: advanced CKD and dialysis.
www.nephjc.com
October 14, 2025 at 6:42 PM
Reposted by Jeyakumar Meyyappan
Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR?
www.nephjc.com/news/2025/10...
www.nephjc.com/news/2025/10...
Protein supplementation in CKD: The Visual Abstract — NephJC
We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?
www.nephjc.com
October 13, 2025 at 1:14 PM
Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR?
www.nephjc.com/news/2025/10...
www.nephjc.com/news/2025/10...
ISPD APCN Malaysia 2025 . Talk on fungal peritonitis in CAPD
September 14, 2025 at 3:24 AM
ISPD APCN Malaysia 2025 . Talk on fungal peritonitis in CAPD
Reposted by Jeyakumar Meyyappan
🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky
@brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts
*the original article from @asnpublications.bsky.social
www.nephjc.com/news/nephjc-...
@brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts
*the original article from @asnpublications.bsky.social
www.nephjc.com/news/nephjc-...
NephJC Shorts: MCD and FSGS Outcomes — NephJC
A NephJC Shorts discussion of the long term data on kidney failure in FSGS and MCD
www.nephjc.com
September 6, 2025 at 5:00 PM
🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky
@brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts
*the original article from @asnpublications.bsky.social
www.nephjc.com/news/nephjc-...
@brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts
*the original article from @asnpublications.bsky.social
www.nephjc.com/news/nephjc-...
Reposted by Jeyakumar Meyyappan
another great quote in that chapter
"Stigma is a way of saying, "You deserved to have this happen," but implied within the stigma is also,
"And I don't deserve it, so I don't need to worry about it happening to me."
Stop blaming people for having a disease #NephJC"
"Stigma is a way of saying, "You deserved to have this happen," but implied within the stigma is also,
"And I don't deserve it, so I don't need to worry about it happening to me."
Stop blaming people for having a disease #NephJC"
August 20, 2025 at 2:00 AM
another great quote in that chapter
"Stigma is a way of saying, "You deserved to have this happen," but implied within the stigma is also,
"And I don't deserve it, so I don't need to worry about it happening to me."
Stop blaming people for having a disease #NephJC"
"Stigma is a way of saying, "You deserved to have this happen," but implied within the stigma is also,
"And I don't deserve it, so I don't need to worry about it happening to me."
Stop blaming people for having a disease #NephJC"
#nephjc
Jeyakumar Meyyappan from India
“Everything is tuberculosis “Read My second book on a disease. First was “emperor of all maladies “
Jeyakumar Meyyappan from India
“Everything is tuberculosis “Read My second book on a disease. First was “emperor of all maladies “
August 20, 2025 at 1:13 AM
#nephjc
Jeyakumar Meyyappan from India
“Everything is tuberculosis “Read My second book on a disease. First was “emperor of all maladies “
Jeyakumar Meyyappan from India
“Everything is tuberculosis “Read My second book on a disease. First was “emperor of all maladies “
Reposted by Jeyakumar Meyyappan
“Where are the drugs? The drugs are where the disease is not. And where is the disease? The disease is where the drugs are not.”
A powerful book! Looking forward to tomorrow’s book club!
A powerful book! Looking forward to tomorrow’s book club!
August 19, 2025 at 12:20 AM
“Where are the drugs? The drugs are where the disease is not. And where is the disease? The disease is where the drugs are not.”
A powerful book! Looking forward to tomorrow’s book club!
A powerful book! Looking forward to tomorrow’s book club!
Reposted by Jeyakumar Meyyappan
Sometimes more lessons are learned from failures than successes. I've learned quite a bit from working through the challenges of this trial. #NephJC
August 6, 2025 at 1:56 AM
Sometimes more lessons are learned from failures than successes. I've learned quite a bit from working through the challenges of this trial. #NephJC
Reposted by Jeyakumar Meyyappan
😎Check out the VA for HiLO by @sejalplakhani.bsky.social
🆒 This should be quite the discussion, don't miss it!
#NephJC #NephSky
www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstract
🆒 This should be quite the discussion, don't miss it!
#NephJC #NephSky
www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstract
The HiLo Trial - Visual Abstract — NephJC
Is a lower versus higher phosphate target beneficial to patients undergoing hemodialysis? Check out this crisp VA by Dr Sejal Lakhani
www.nephjc.com
August 5, 2025 at 1:16 AM
😎Check out the VA for HiLO by @sejalplakhani.bsky.social
🆒 This should be quite the discussion, don't miss it!
#NephJC #NephSky
www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstract
🆒 This should be quite the discussion, don't miss it!
#NephJC #NephSky
www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstract
Reposted by Jeyakumar Meyyappan
HiLo, HiLo it's off to work we go! ⛏️
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️
www.nephjc.com/news/hilo-tr...
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️
www.nephjc.com/news/hilo-tr...
High or Low Phosphate? Are we Missing the (P)oint? — NephJC
This week, we will discuss the phosphate targets in dialysis. Are you aiming for HIgh or Low?
www.nephjc.com
August 5, 2025 at 1:08 AM
HiLo, HiLo it's off to work we go! ⛏️
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️
www.nephjc.com/news/hilo-tr...
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️
www.nephjc.com/news/hilo-tr...
Reposted by Jeyakumar Meyyappan
Severe AKI in the ICU: Management ca. 2025
#Nephpearls #AKIinICU #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/40578821/
#Nephpearls #AKIinICU #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/40578821/
July 24, 2025 at 1:53 AM
Severe AKI in the ICU: Management ca. 2025
#Nephpearls #AKIinICU #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/40578821/
#Nephpearls #AKIinICU #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/40578821/
July 9, 2025 at 1:03 AM
Reposted by Jeyakumar Meyyappan
With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?'
#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social
#MedSky
www.nephjc.com/news/confide...
#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social
#MedSky
www.nephjc.com/news/confide...
A dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease — NephJC
This week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD.
www.nephjc.com
July 8, 2025 at 1:48 AM
With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?'
#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social
#MedSky
www.nephjc.com/news/confide...
#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social
#MedSky
www.nephjc.com/news/confide...
Check out the blog summary . CONFIDENCE
How confident are we starting sglt 2 i + nsmra upfront for patients with diabetes and kidney diseases ?
www.nephjc.com/news/confide...
How confident are we starting sglt 2 i + nsmra upfront for patients with diabetes and kidney diseases ?
www.nephjc.com/news/confide...
A dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease — NephJC
This week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD.
www.nephjc.com
July 8, 2025 at 2:59 AM
Check out the blog summary . CONFIDENCE
How confident are we starting sglt 2 i + nsmra upfront for patients with diabetes and kidney diseases ?
www.nephjc.com/news/confide...
How confident are we starting sglt 2 i + nsmra upfront for patients with diabetes and kidney diseases ?
www.nephjc.com/news/confide...
Reposted by Jeyakumar Meyyappan
Check out the latest KDIGO Direct: kdigo.co/KDIGO-Direct...
In this issue:
📗 Nephrotic Syndrome in Children GL publishes
📢 Dr. Wanner elected KDIGO Co-Chair
💔 KDIGO mourns Dr. Rinaldo Bellomo
🌍 KDIGO convenes Green Dialysis Conference
🏛️ KDIGO at #ERA25
🎥 New resources on #ADPKD, #C3G, #CKM & #IgAN
In this issue:
📗 Nephrotic Syndrome in Children GL publishes
📢 Dr. Wanner elected KDIGO Co-Chair
💔 KDIGO mourns Dr. Rinaldo Bellomo
🌍 KDIGO convenes Green Dialysis Conference
🏛️ KDIGO at #ERA25
🎥 New resources on #ADPKD, #C3G, #CKM & #IgAN
May 16, 2025 at 3:52 PM